Identification Generic Name (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate DrugBank Accession Number DB07596 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate (DB07596) ×  Close Weight Average: 404.523  Monoisotopic: 404.176978084  Chemical Formula C 21 H 28 N 2 O 4 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Carbonic anhydrase 2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. Kingdom Organic compounds Super Class Lipids and lipid-like molecules Class Steroids and steroid derivatives Sub Class Estrane steroids Direct Parent Estrane steroids Alternative Parents Phenanthrenes and derivatives  /  Tetralins  /  Anisoles  /  Alkyl aryl ethers  /  Organic sulfuric acids and derivatives  /  Nitriles  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives Substituents Alkyl aryl ether  /  Anisole  /  Aromatic homopolycyclic compound  /  Benzenoid  /  Carbonitrile  /  Estrane-skeleton  /  Ether  /  Hydrocarbon derivative  /  Nitrile  /  Organic nitrogen compound Molecular Framework Aromatic homopolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key NTSPHKOMJMBWOU-NNKXXINSSA-N InChI InChI=1S/C21H28N2O4S/c1-21-9-7-15-16(18(21)6-4-14(21)8-10-22)5-3-13-11-20(27-28(23,24)25)19(26-2)12-17(13)15/h11-12,14-16,18H,3-9H2,1-2H3,(H2,23,24,25)/t14-,15+,16-,18+,21-/m1/s1 IUPAC Name (1R,3aS,3bS,9bS,11aR)-1-(cyanomethyl)-8-methoxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl sulfamate SMILES [H][C@]1(CC#N)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(N)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C References General References Not Available External Links PubChem Compound 11188898 PubChem Substance 99444067 ChemSpider 9363982 BindingDB 50372895 ChEMBL CHEMBL408967 ZINC ZINC000029135869 PDBe Ligand CTF PDB Entries 3bet Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00659 mg/mL ALOGPS logP 3.9 ALOGPS logP 3.24 Chemaxon logS -4.8 ALOGPS pKa (Strongest Acidic) 10.5 Chemaxon pKa (Strongest Basic) -4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 102.41 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 106.17 m 3 ·mol -1 Chemaxon Polarizability 44.39 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.939 Caco-2 permeable - 0.6355 P-glycoprotein substrate Non-substrate 0.5973 P-glycoprotein inhibitor I Non-inhibitor 0.5925 P-glycoprotein inhibitor II Non-inhibitor 0.8665 Renal organic cation transporter Non-inhibitor 0.7901 CYP450 2C9 substrate Non-substrate 0.8865 CYP450 2D6 substrate Non-substrate 0.7894 CYP450 3A4 substrate Substrate 0.6492 CYP450 1A2 substrate Non-inhibitor 0.621 CYP450 2C9 inhibitor Non-inhibitor 0.698 CYP450 2D6 inhibitor Non-inhibitor 0.8652 CYP450 2C19 inhibitor Non-inhibitor 0.6015 CYP450 3A4 inhibitor Non-inhibitor 0.8598 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5162 Ames test Non AMES toxic 0.5456 Carcinogenicity Non-carcinogens 0.5645 Biodegradation Not ready biodegradable 0.9973 Rat acute toxicity 2.5104 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.612 hERG inhibition (predictor II) Inhibitor 0.6433    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 1500 N/A N/A A30883 
 
 
  Details 
 
 
   Binding Properties 1.  Carbonic anhydrase 2 Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion in... Gene Name CA2 Uniprot ID P00918 Uniprot Name Carbonic anhydrase 2 Molecular Weight 29245.895 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:23 / Updated at June 12, 2020 16:52 